艾昆纬- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于艾昆纬公司

IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

艾昆纬简介



公司代码IQV

公司名称IQVIA Holdings Inc

上市日期May 09, 2013

CEOBousbib (Ari)

员工数量88000

证券类型Ordinary Share

年结日May 09

公司地址2400 Ellis Road

城市DURHAM

上市交易所NASDAQ OMX NASDAQ Basic NYSE

国家United States of America

邮编27703

电话19199982000

网址https://ir.iqvia.com/

公司代码IQV

上市日期May 09, 2013

CEOBousbib (Ari)

艾昆纬公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-907.00%

Mr. John G. Danhakl

Independent Director

30.85K

-117138.00%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+1592.00%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+1592.00%

Ms. Carol J. Burt

Independent Director

7.01K

+1047.00%

Mr. James A. Fasano

Independent Director

2.74K

+1676.00%

Mr. John P. Connaughton

Independent Director

1.05K

+1047.00%

Mr. Bhavik Patel

President, Commercial Solutions

863.00

-84.00%

名称

名称/职务

职务

持股

持股变动

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-907.00%

Mr. John G. Danhakl

Independent Director

30.85K

-117138.00%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+1592.00%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+1592.00%

收入明细

单位: USD更新时间: 1月6日周二

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

Americas

1.93B

47.15%

Europe & Africa Region

1.30B

31.63%

Asia Pacific Region

870.00M

21.22%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 1月10日周六

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

11.54%

Harris Associates L.P.

6.71%

BlackRock Institutional Trust Company, N.A.

5.57%

State Street Investment Management (US)

4.45%

GIC Private Limited

3.86%

其他

67.87%

持股股东

占比

The Vanguard Group, Inc.

11.54%

Harris Associates L.P.

6.71%

BlackRock Institutional Trust Company, N.A.

5.57%

State Street Investment Management (US)

4.45%

GIC Private Limited

3.86%

其他

67.87%

股东类型

持股股东

占比

Investment Advisor

47.72%

Investment Advisor/Hedge Fund

36.41%

Sovereign Wealth Fund

4.96%

Pension Fund

4.15%

Hedge Fund

3.24%

Research Firm

2.37%

Bank and Trust

2.01%

Individual Investor

0.92%

Family Office

0.15%

机构持股



更新时间: 1月1日周四

报告期

机构数

持股数

持股占比

持股变动

2025Q4

2132

171.19M

100.94%

-15.17M

2025Q3

2061

175.98M

103.33%

-829.63K

2025Q2

2053

166.70M

98.05%

-9.45M

2025Q1

2083

168.53M

97.38%

-9.36M

2024Q4

2059

171.87M

97.45%

+3.00M

2024Q3

2008

173.01M

95.44%

+863.78K

2024Q2

1977

164.85M

90.43%

-7.68M

2024Q1

1950

165.50M

90.84%

-10.38M

2023Q4

1948

168.90M

93.03%

-6.38M

2023Q3

1925

170.01M

92.82%

-4.41M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

19.41M

11.4%

-186.59K

-0.95%

Sep 30, 2025

Harris Associates L.P.

11.39M

6.69%

-365.92K

-3.11%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

9.44M

5.54%

+67.42K

+0.72%

Sep 30, 2025

State Street Investment Management (US)

7.55M

4.43%

-75.92K

-1.00%

Sep 30, 2025

GIC Private Limited

6.54M

3.84%

-2.59M

-28.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.35M

2.55%

+132.36K

+3.14%

Sep 30, 2025

CPP Investments

4.12M

2.42%

-52.91K

-1.27%

Sep 30, 2025

AllianceBernstein L.P.

3.60M

2.11%

+41.64K

+1.17%

Sep 30, 2025

Boston Partners

3.56M

2.09%

+1.58M

+80.09%

Sep 30, 2025

Artisan Partners Limited Partnership

3.43M

2.02%

+161.09K

+4.92%

Sep 30, 2025

持股ETF



更新时间: 12月2日周二

机构名称

占比

First Trust Nasdaq Lux Digi Health Solutions ETF

9.1%

Langar Global HealthTech ETF

7.83%

Global X HealthTech ETF

5.5%

VanEck Biotech ETF

4.98%

iShares Biotechnology ETF

3.23%

iShares Health Innovation Active ETF

3.05%

Adaptive Core ETF

3.04%

Invesco Bloomberg Pricing Power ETF

2.24%

Running Oak Efficient Growth ETF

2.16%

Invesco Zacks Mid-Cap ETF

2.08%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比9.1%

Langar Global HealthTech ETF

占比7.83%

Global X HealthTech ETF

占比5.5%

VanEck Biotech ETF

占比4.98%

iShares Biotechnology ETF

占比3.23%

iShares Health Innovation Active ETF

占比3.05%

Adaptive Core ETF

占比3.04%

Invesco Bloomberg Pricing Power ETF

占比2.24%

Running Oak Efficient Growth ETF

占比2.16%

Invesco Zacks Mid-Cap ETF

占比2.08%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据

艾昆纬

关于 艾昆纬 公司

艾昆纬简介

艾昆纬公司高管

收入明细

股东统计

机构持股

股东持股明细

持股ETF

分红派息

拆合股

关于艾昆纬公司